Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 Million in Gross Proceeds
09. Dezember 2011 08:35 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that it has entered into definitive agreements with institutional investors...
Oxygen Biotherapeutics to Present at 23rd Annual Piper Jaffray Healthcare Conference
22. November 2011 11:20 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that Chief Financial Officer and Interim CEO Michael Jebsen will present at...
Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange
27. Oktober 2011 16:45 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the...
Oxygen Biotherapeutics Names Dr. Ronald Blanck Chairman of the Board
30. September 2011 17:59 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Ronald R. Blanck, DO, was appointed Chairman of the...
Oxygen Biotherapeutics Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders
19. September 2011 17:25 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
Oxygen Biotherapeutics Announces Dismissal of Chris J. Stern as CEO and Appointments of Michael B. Jebsen as Interim CEO and Rene Eckert as Interim Chairman
24. August 2011 17:15 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Aug. 24, 2011 (GLOBE NEWSWIRE) -- The Board of Directors of Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Chris J. Stern is no longer...
Photo Release -- Beat the Summertime Skin Blues With Dermacyte(R) Summer Rescue Bundle to Soothe Dry Skin and Bring Back a Youthful Glow
01. August 2011 09:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Let's face it: summer is fun, but it can be tough on your skin. Most of us spend more hours outdoors in summer than during any other season doing...
Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte(R) PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke
25. Juli 2011 02:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 25, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Aurum Biosciences, Ltd. of Glasgow, Scotland, today...
Global Interest in the Potential Medical Benefits of Novel Perfluorocarbon At All Time High
20. Juli 2011 08:00 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- University and educational institution researchers from the United Kingdom, Switzerland and the United States all have one thing in common: an...
Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2011
14. Juli 2011 18:02 ET
|
Oxygen Biotherapeutics, Inc.
MORRISVILLE, N.C., July 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...